Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2022-03-25 Director's Dealing
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
220325 - Disposals of own shares_ENG.pdf
Director's Dealing Classification · 1% confidence The document is explicitly titled "Disposal of own shares" and details numerous transactions where UCB disposed of its own shares OTC following the exercise of stock options by personnel under various LTI Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). This matches the definition for Transaction in Own Shares (POS). The document is a formal press release announcing these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive data itself.
2022-03-25 English
220325 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and is dated March 25, 2022. It details transactions where UCB SA alienated (sold/transferred) its own shares following the exercise of options by employees, as required by Belgian Royal Decree (Article 8:6). This activity directly relates to the company managing its own share capital, specifically through the disposal of treasury shares, often linked to employee compensation plans. This aligns precisely with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a Director's Dealing (DIRS) as it concerns company-wide employee option exercises, not just individual director trades.
2022-03-25 French
220325 - Vervreemding van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB shares were delivered to employees as part of long-term incentive plans (Stock Option Plans). This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation/share schemes. This aligns perfectly with the definition of 'Transaction in Own Shares' (Code: POS). It is not a general regulatory filing (RNS) because it is highly specific, nor is it a Director's Dealing (DIRS) as it relates to employee option exercises rather than executive personal trades, although there is overlap. The most precise fit is POS.
2022-03-25 Dutch
Bio Cédric van Rijckevorsel - ucb.com 2022 - FINAL.pdf
Board/Management Information Classification · 1% confidence The document provides detailed biographical information, professional experience, education, and external appointments for an individual named Cédric van Rijckevorsel, who is identified as a 'Member of the Board'. This type of disclosure, focusing on the background and qualifications of a director or senior executive, strongly aligns with documents related to corporate governance or management structure. Specifically, it details the profile of a board member. This fits best under the 'Board/Management Information' category, which covers announcements of changes or profiles of directors/senior management.
2022-03-25 English
Bio Kay Davies - ucb.com 2022 - FINAL.pdf
Board/Management Information Classification · 1% confidence The document provides detailed biographical information, professional experience, education, and current appointments for an individual named Kay Davies, who is identified as an Independent Director and a member of the Governance, Nomination and Compensation Committee. This type of disclosure, focusing on the background and qualifications of board members and senior management, aligns directly with the definition of Board/Management Information (MANG). It is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI), but rather specific information about a director.
2022-03-25 English
Bio Jean-Christophe Tellier - ucb.com 2022 - FINAL.pdf
Board/Management Information Classification · 1% confidence The document provides a detailed biography, professional experience, key positions, and education history for an individual named Jean-Christophe Tellier, who is the CEO and Chairman of the Executive Committee. This type of biographical and role-specific information, especially concerning senior leadership, strongly aligns with documents detailing company governance or management structure. Since the text focuses entirely on the profile of a key executive, it best fits the 'Board/Management Information' category, which covers announcements of changes or profiles of senior management.
2022-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.